Yixintang invests CNY 50m in structured deposits

Yixintang Pharmaceutical Group (SZSE:002727) announced it has invested CNY 50 million in structured deposits, furthering its strategy of using temporarily idle funds for cash management. The investments include CNY 5 million in a "W款2025年第713期" product with Guangfa Bank, offering a floating yield between 1% and 2.1% annually, maturing on October 9, 2025. Previously, the company invested CNY 5 million in a structured deposit product from China Citic Bank. These investments align with a shareholder-approved plan to manage up to CNY 2.5 billion in idle funds, seeking to improve capital efficiency without impacting ongoing projects or daily operations. The company will monitor market conditions and manage risks through internal controls and audits.